Morrow J William 4

Accession 0001209191-20-056263

CIK 0000860730other

View on SEC.gov Company Profile

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 8:35 PM ET

Size

38.1 KB

Accession

0001209191-20-056263

Insider Transaction Report

Form 4

Period: 2020-10-27

HCA Healthcare, Inc.HCA

Morrow J William

SVP - Finance and Treasurer

Transactions

Exercise/Conversion
Common Stock
2020-10-27$37.18/sh+10,625$395,038→ 11,983.224 total
Sale
Common Stock
2020-10-27$133.95/sh−1,625$217,663→ 4,862 total(indirect: By LM 2020 GRAT)
Exercise/Conversion
Stock Appreciation Right
2020-10-27−6,375→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (6,375 underlying)
Exercise/Conversion
Stock Appreciation Right
2020-10-27−4,250→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (4,250 underlying)
Sale
Common Stock
2020-10-27$133.79/sh−600$80,275→ 1,764 total(indirect: By Trust)
Gift
Common Stock
2020-05-01−6,487→ 7,846.224 total
Gift
Common Stock
2020-05-01+6,487→ 6,487 total(indirect: By Spouse)
Gift
Common Stock
2020-05-08−10→ 7,836.224 total
Gift
Common Stock
2020-05-11−6,487→ 0 total(indirect: By Spouse)
Gift
Common Stock
2020-05-11+6,487→ 6,487 total(indirect: By LM 2020 GRAT)
Gift
Common Stock
2020-05-12−6,478→ 1,358.224 total
Gift
Common Stock
2020-05-12+6,478→ 6,478 total(indirect: By JM 2020 GRAT)
Exercise/Conversion
Common Stock
2020-10-27$47.97/sh+12,025$576,839→ 24,008.224 total
Sale
Common Stock
2020-10-27$134.71/sh−1,615$217,555→ 4,863 total(indirect: By JM 2020 GRAT)
Exercise/Conversion
Stock Appreciation Right
2020-10-27−6,500→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (6,500 underlying)
Tax Payment
Common Stock
2020-10-27$130.56/sh−13,432$1,753,682→ 10,576.224 total
Exercise/Conversion
Stock Appreciation Right
2020-10-27−5,525→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (5,525 underlying)

Footnotes (6)

[F1]Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.7046 to $134.7218, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
[F4]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
[F5]The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
[F6]The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

Documents

2 files

Issuer

HCA Healthcare, Inc.

CIK 0000860730

→

Entity typeother

Related Parties

filerCIK 0001696543

Filing Metadata

Form type: 4
Filed: Oct 28, 8:00 PM ET
Accepted: Oct 29, 8:35 PM ET
Size: 38.1 KB

View on SEC.gov